FMD

L-Nutra Reveals World's First Patent-Pending Protein Formula for Healthy Aging to Pioneer Nutrition-Focused Health Solutions

Retrieved on: 
Tuesday, April 9, 2024
Dicarboxylic acid, Health, Meat, Metabolism, Vitamin, Longevity, FMD, Facial muscles, Poultry, Environment, Rejuvenation, Lactose, Insulin, Research, GMO, Doctor of Philosophy, MD, Mineral, Life, Fruit, Ageing, Dietary supplement

LOS ANGELES, April 9, 2024 /PRNewswire/ -- In a remarkable leap forward for nutrition and healthy aging, L-Nutra , the leading nutrition technology company, proudly introduces the world's first patent-pending protein designed to support healthy aging – L-Protein .

Key Points: 
  • LOS ANGELES, April 9, 2024 /PRNewswire/ -- In a remarkable leap forward for nutrition and healthy aging, L-Nutra , the leading nutrition technology company, proudly introduces the world's first patent-pending protein designed to support healthy aging – L-Protein .
  • This first-of-its-kind protein formula was developed by L-Nutra to support muscle function and healthspan.
  • Similarly, inadequate protein intake, as demonstrated in some strict vegan diets, does not produce enough of the necessary growth factors for optimal muscle support and healthy aging.
  • L-Protein is another nutritional milestone to complement the healthy aging benefits of the Prolon Fasting Mimicking Diet (FMD) , L-Nutra's flagship program.

Fairbanks Morse Defense’s Hunt Valve to Produce First 3D Printed Valve Assembly for U.S. Navy Submarines

Retrieved on: 
Wednesday, April 3, 2024
Technology, Engineering, Manufacturing, Military, Maritime, Machinery, Defense, Transport, Other Defense, Software, Contracts, Other Manufacturing, Electronic Design Automation, Government Technology, FMD, Alloy, 3D, United States Navy, Lincoln Electric, Navy

Hunt Valve, a Fairbanks Morse Defense (FMD) company, has been awarded a contract by the Maritime Sustainment Technology and Innovation Consortium (MSTIC) to produce a 3D printed valve assembly for installation on U.S. Navy submarines, positioning the defense contractor as a first mover in this sector.

Key Points: 
  • Hunt Valve, a Fairbanks Morse Defense (FMD) company, has been awarded a contract by the Maritime Sustainment Technology and Innovation Consortium (MSTIC) to produce a 3D printed valve assembly for installation on U.S. Navy submarines, positioning the defense contractor as a first mover in this sector.
  • “The utilization of additive manufacturing assembly with copper-nickel for large valve production is a real step forward for our industry,” said Andrew Pfister, Vice President, Aftermarket and Product Development at Fairbanks Morse Defense.
  • Hunt Valve’s contract with MSTIC will allow the 3D valve to be installed on any U.S. submarine class.
  • Once “printed,” the valve body is delivered to Hunt Valve to manufacture the remaining components using the standard manufacturing method and then assemble all the parts to create the full valve assembly .

Fairbanks Morse Defense Continues Expanding Turnkey Solutions with AMMCON Acquisition

Retrieved on: 
Tuesday, March 26, 2024
Other Manufacturing, Contracts, Maritime, Engineering, Transport, Military, Manufacturing, Machinery, Defense, Military Sealift Command, Acquisition, Columbia, FMD, Ford, Coast guard

Fairbanks Morse Defense (FMD), a portfolio company of Arcline Investment Management, has acquired AMMCON Corp. , a Jacksonville- based fittings and assembled components manufacturer.

Key Points: 
  • Fairbanks Morse Defense (FMD), a portfolio company of Arcline Investment Management, has acquired AMMCON Corp. , a Jacksonville- based fittings and assembled components manufacturer.
  • The defense contractor’s acquisition continues its expansion and commitment to providing critical components to the U.S. Navy and other marine defense customers.
  • FMD’s acquisition enables AMMCON to expand its products to additional platforms and customers across the U.S. Navy , Coast Guard , and Military Sealift Command .
  • “Over the past 50 years, we have built our business as a defense contractor by honing our quality to pinpoint accuracy to the needs of defense,” said Darrell Grow, AMMCON CEO.

L-Nutra's Groundbreaking Study Revolutionizes Type 2 Diabetes Management Through Fasting Mimicking Nutrition Technology

Retrieved on: 
Thursday, April 4, 2024
Glycated hemoglobin, Metabolism, FMD, Type 2 diabetes, Disease, Insulin, Diabetes, Patient, Research, Fasting, Standard of care, Food, Doctor of Philosophy, Diet, Insulin resistance, Clinical trial, Type 2, Safety, Waist, BMI, Metformin, Movement, Prediabetes, Pharmaceutical industry

This randomized, controlled, assessor-blinded trial introduces a new paradigm in diabetes management, focusing on "glycemic management,'' a new metric used to measure efficacy by medication reduction.

Key Points: 
  • This randomized, controlled, assessor-blinded trial introduces a new paradigm in diabetes management, focusing on "glycemic management,'' a new metric used to measure efficacy by medication reduction.
  • Glycemic Management: FMD participants demonstrated superior glycemic management, with 53% showing improvement, compared to only 8% in the control group.
  • L-Nutra's patented and clinically backed nutrition technology food formulations are effective in supporting metabolism, cell renewal, and muscle protection by mimicking the reset and rejuvenation pathways of fasting.
  • "With the Fasting Mimicking Diet, we have successfully enhanced the natural rejuvenating power of fasting with food which has made the regression and remission of diabetes within every patient's reach.

L-Nutra Health® Pioneers New, Innovative Therapeutic Healthcare Model with Official Diabetes Patent

Retrieved on: 
Tuesday, March 19, 2024
Stem cell, Glucose, Facial muscles, Longevity, Regeneration, FMD, Health, Diabetes, Patient, Harvard University, Weight loss, Hope, Joslin Diabetes Center, Insulin resistance, Patent, Physician, Ageing, Pharmaceutical industry

With this historic achievement in nutrition-led healthcare, L-Nutra Health® solidifies its position as the authoritative leader in science-backed nutrition technology.

Key Points: 
  • With this historic achievement in nutrition-led healthcare, L-Nutra Health® solidifies its position as the authoritative leader in science-backed nutrition technology.
  • The comprehensive program includes supervision by lifestyle medicine physicians and personalized support from dietitians uniquely trained in longevity and diabetes.
  • Through nutrition, L-Nutra Health® is redefining the landscape of type 2 diabetes management and the speed of regression.
  • "This patent stands as a testament to our steadfast commitment to providing pioneering solutions that define a new therapeutic category, positioning L-Nutra Health® at the forefront of healthcare."

Study on Foot-and-Mouth Disease Virus Results in Submission for Additional EPA Label

Retrieved on: 
Monday, March 11, 2024
Hydrogen, DARPA, Hospital, Restaurant, Hydrogen peroxide, Livestock, Disinfectant, Food safety, Research, Deer, Annual report, Stainless steel, DHS, Animal, Sheep, Goat, Global health, FMD, Meat, Contagious disease, Foot-and-mouth disease virus, COVID-19, School, Virus, FMDV, TAD, EPA, Decontamination, Infection, Police, Science, PIADC, Foot-and-mouth disease, Pharmaceutical industry

This significant advancement supports the Company’s submission for an additional EPA label.

Key Points: 
  • This significant advancement supports the Company’s submission for an additional EPA label.
  • Foot-and-mouth disease (FMD) represents a critical global threat, being an extremely contagious disease affecting a wide range of cloven-hoofed animals including cows, pigs, sheep, goats, and deer.
  • TOMI’s recent study has proven SteraMist iHP technology to eliminate infectious FMDV from both porous (concrete) and non-porous (stainless steel) surfaces in the presence of organic soil load.
  • Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.

Minister MacAulay announces support for Animal Health Canada's work to prevent and prepare for animal disease outbreaks

Retrieved on: 
Thursday, March 7, 2024
FAP, CFIA, Livestock, Food safety, Deer, Investment, Viral disease, Pig, Executive Schedule, Cattle, Animal, Sheep, AAFC, ASF, Government, Goat, FMD, Risk, African swine fever virus, Food, Canadian Food Inspection Agency, Health, Pithing, Disease, Foot, Research, Human

Today the Honourable Lawrence MacAulay, Minister of Agriculture and Agri-Food, announced an investment of up to $1,697,850 to Animal Health Canada to support their role in foreign animal disease prevention and preparedness efforts in Canada, including for African swine fever (ASF) and Foot and Mouth Disease (FMD).

Key Points: 
  • Today the Honourable Lawrence MacAulay, Minister of Agriculture and Agri-Food, announced an investment of up to $1,697,850 to Animal Health Canada to support their role in foreign animal disease prevention and preparedness efforts in Canada, including for African swine fever (ASF) and Foot and Mouth Disease (FMD).
  • Animal Health Canada brings together the agriculture industry, and federal, provincial and territorial partners to provide input on a cohesive, functional and responsive farmed animal health and welfare system in Canada.
  • Animal Health Canada's coordination role with partners and stakeholders has been key to Canada's animal disease prevention, and to ensuring our livestock sector is ready in the event of an outbreak.
  • -       The Honourable Lawrence MacAulay, Minister of Agriculture and Agri-Food
    "We're pleased we are continuing our collaboration with industry and government to not only prevent and control African swine fever in Canada, but other foreign animal disease outbreaks."

L-Nutra Unveils Groundbreaking Research on Fasting Mimicking Diets (FMDs) and Reduced Biological Age Score

Retrieved on: 
Wednesday, February 28, 2024
Nature, The, NHANES, Ageing, Health, Food, Harvard University, Joslin Diabetes Center, University of Southern California, FMD, Longevity, Facial muscles, University, Fasting, Yale University, Nature Communications, Life, Research, Medicine, Dietary supplement

LOS ANGELES, Feb. 28, 2024 /PRNewswire/ -- L-Nutra Inc., a leading nutrition technology company developing evidence-based Nutrition for Longevity and Nutrition as Medicine programs, is excited to announce the release of a groundbreaking longevity and healthy aging study published in Nature Communications, a prestigious Nature portfolio journal. The data suggests that following three consecutive monthly rounds of ProLon® 5-Day may decrease a person's biological age score by 2.5 years. 

Key Points: 
  • The data suggests that following three consecutive monthly rounds of ProLon® 5-Day may decrease a person's biological age score by 2.5 years.
  • L-Nutra's flagship product, ProLon® 5-day Fasting Mimicking Diet (FMD), the first patented precision nutrition program shown to support cellular rejuvenation and metabolic reset effects of prolonged fasting, was provided to participants.
  • This research further solidifies L-Nutra's commitment to advancing scientific understanding and practical applications of nutrition for living longer and healthier.
  • This study marks a significant step forward in understanding the effect of fasting-mimicking diets (FMD) in cellular rejuvenation, metabolic reset, and supporting healthy living.

L-Nutra Unveils Groundbreaking Study on Fasting Mimicking Diets (FMDs) and Chronic Lymphocytic Leukemia

Retrieved on: 
Tuesday, February 13, 2024
Breast cancer, Quality of life, CLL, FMD, Food, Chronic lymphocytic leukemia, Bortezomib, Leukemia, Patient, Fasting, Carfilzomib, Medicine, Research, Mouse, Pharmaceutical industry

CLL is the most prevalent form of leukemia in Western countries, and this groundbreaking research suggests a promising avenue for more effective treatment options.

Key Points: 
  • CLL is the most prevalent form of leukemia in Western countries, and this groundbreaking research suggests a promising avenue for more effective treatment options.
  • The study focused on the synergistic effects of cyclic fasting combined with proteasome inhibitors, experimental medication showing early promise for the treatment of CLL.
  • This suggests a potential benefit of fasting mimicking diets (FMDs) in treatment of milder CLL cases even without additional interventions.
  • The findings from this study open up potential new possibilities for CLL treatment strategies and food as medicine in general.

Solidsoft Reply Spearheads Ground-breaking Migration of Finland’s National Medicines Verification System

Retrieved on: 
Thursday, February 1, 2024
Business, Other Health, Other Professional Services, Pharmaceutical, Telecommunications, Software, Artificial Intelligence, Medical Devices, Consulting, Data Management, Professional Services, Technology, Managed Care, Medical Supplies, Data Analytics, Health, Apps, Applications, Health Technology, Partnership, Azure, Knowledge, FMD, EXM, Safety, Internet, Medication, Ecosystem, Big data, Microsoft, Microsoft Azure, Documentation, Health care, Traceability, Insurance, Engineering, Cloud computing, STAR, Medical device

Solidsoft Reply , a Reply Group company specialising in creating Microsoft Azure cloud-based enterprise solutions, has successfully migrated Finland's National Medicines Verification System to its National Blueprint solution.

Key Points: 
  • Solidsoft Reply , a Reply Group company specialising in creating Microsoft Azure cloud-based enterprise solutions, has successfully migrated Finland's National Medicines Verification System to its National Blueprint solution.
  • National Blueprint Solution is Solidsoft Reply's Own National Verification System - A system built on Microsoft Azure cloud technology to verify medicines in accordance to the EU Falsified Medicines Directive (FMD) .
  • This notable accomplishment marks a pioneering step for the European Medicines Verification System (EMVS).
  • David Eccles, Partner at Solidsoft Reply, remarked, “This successful migration is not just a remarkable achievement but also a testament to our engineering expertise and collaborative ethos at Solidsoft Reply.